Radiation Oncology Associates of New York Becomes the First to Offer Varian Medical Systems’ (VAR) RapidArc™ Radiotherapy Technology
Posted on Thursday, July 10th, 2008 | In Current Market News, OTCBB Markets, Small & Micro Cap, Stocks to WatchVarian Medical Systems (VAR) is a manufacturer of medical technology for treating cancer and other medical conditions with radiotherapy, brachytherapy, and radiosurgery. The company also supplies X-ray tubes and digital image detectors for imaging in medical, scientific, and industrial applications, and its high energy imaging systems are also used for screening cargo. Varian operates businesses in several areas: Oncology Systems, X-ray Products, and Security and Inspection Products Group.
The company announced this week that by using the company’s RapidArc™ radiotherapy technology two prostate cancer patients, the first people in New York, were able to receive a faster, more comfortable form of highly accurate radiotherapy in pioneering treatments at Radiation Oncology Associates of New York. The clinic is the largest freestanding radiation oncology practice in New York, with facilities in Long Island, and the surrounding New York City boroughs and counties. Doctors at the clinic, which will soon change its name to Advanced Radiation Centers of New York, are delivering image-guided intensity-modulated radiotherapy (IMRT) two to eight times faster than earlier technologies.
Two patients have begun receiving RapidArc treatments, delivered in less than two minutes and completed in two simple steps. First, clinicians capture a set of high-resolution X-ray images of the targeted tumor and surrounding anatomy and use these to position the patient for treatment. Then, once the patient has been positioned properly, RapidArc delivers the prescribed dose in less than two minutes with a single rotation of the treatment machine around the patient. Dr. Shawn Zimberg, medical director for Radiation Oncology stated, “RapidArc enables us to quickly deliver IMRT treatments that are designed to target tumors and malignancies very precisely while dramatically reducing the exposure of surrounding tissues.â€
Let us hear your thoughts below:
Last 5 posts by QualityStocks
- Omnicity Corp. (OMCY.OB) Announces Addition of New Board Member - November 20th, 2009
- Muscle Flex, Inc. (MFLI.PK) Announces Release Time for the BUDDY Tablet Caddy Two-Minute Commercial and Landing Page - November 20th, 2009
- Artfest International, Inc. (ARTS.OB) Announces Revenue Profit Jumps - November 20th, 2009
- Omnicity Corp.’s (OMCY.OB) Recently-Issued Corporate Update - November 20th, 2009
- Soligenix Inc. (SNGX.OB) Taking Steps to Meet Challenges of Vaccine Technology and Biological Warfare - November 20th, 2009
![]() About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |



